Literature DB >> 25051654

Criminal law and HIV testing: empirical analysis of how at-risk individuals respond to the law.

Sun Goo Lee.   

Abstract

This Note assesses the effect of laws that specifically criminalize behaviors that expose others to the human immunodeficiency virus (HIV). This Note examines the relationship between HIV testing decisions by high-risk individuals and the existence of these HIV-specific statutes, as well as the amount of media coverage related to them. One of the main reasons public health experts criticize criminalization of HIV-exposing behavior is that it may discourage at-risk individuals from undergoing HIV testing. This argument, however, remains empirically untested to date. This study quantitatively examines whether at-risk individuals living in jurisdictions with HIV-specific statutes are less likely to report having been tested for HIV in the past year compared to those living in jurisdictions without HIV-specific statutes. Regression analysis is conducted using data collected in the United States over a seven-year span. The results show that at-risk individuals residing in states with HIV-specific statutes are no less likely to report having been tested for HIV than those who live in other states. However, the number of people who reported that they had been tested for HIV is inversely correlated with the frequency of newspaper coverage of criminalization of HIV-exposing behavior. These findings imply that at-risk individuals' HIV testing is associated with media coverage of criminalizing HIV-exposing behavior. The negative impact that criminal law has on HIV testing rates could be a serious public health threat. Testing is often the initial step in public health interventions that most effectively modify the risky behavior of HIV-positive individuals. The adverse consequence of criminalization should weigh heavily in the design and application of criminal sanctions for HIV-exposing behavior. In addition, future research should further explore the relationships between criminalization, media coverage of criminalization, and HIV testing decisions for a more nuanced understanding of the consequences of criminalization.

Entities:  

Mesh:

Year:  2014        PMID: 25051654

Source DB:  PubMed          Journal:  Yale J Health Policy Law Ethics        ISSN: 1535-3532


  5 in total

Review 1.  Criminalization of HIV Exposure: A Review of Empirical Studies in the United States.

Authors:  Dini Harsono; Carol L Galletly; Elaine O'Keefe; Zita Lazzarini
Journal:  AIDS Behav       Date:  2017-01

2.  Historical and Current Trends in HIV Criminalization in South Carolina: Implications for the Southern HIV Epidemic.

Authors:  Deanna Cann; Sayward E Harrison; Shan Qiao
Journal:  AIDS Behav       Date:  2019-10

3.  Lack of awareness in both patients and physicians contributes to a high rate of late presentation in a South West German HIV patient cohort.

Authors:  J M Kittner; L von Bialy; J Wiltink; T Thomaidis; B Gospodinov; A Rieke; F Katz; T Discher; K Rath; B Claus; G Held; G Friese; B Schappert; M Schuchmann; P R Galle
Journal:  Infection       Date:  2015-01-20       Impact factor: 3.553

4.  HIV criminalization exacerbates subpar diagnosis and treatment across the United States: response to the 'Association of HIV diagnosis rates and laws criminalizing HIV exposure in the United States'.

Authors:  Pratha Sah; Meagan C Fitzpatrick; Abhishek Pandey; Alison P Galvani
Journal:  AIDS       Date:  2017-11-13       Impact factor: 4.177

5.  Associations between HIV testing and multilevel stigmas among gay men and other men who have sex with men in nine urban centers across the United States.

Authors:  Kate E Dibble; Sarah M Murray; John Mark Wiginton; Jessica L Maksut; Carrie E Lyons; Rohin Aggarwal; Jura L Augustinavicius; Alia Al-Tayyib; Ekow Kwa Sey; Yingbo Ma; Colin Flynn; Danielle German; Emily Higgins; Bridget J Anderson; Timothy W Menza; E Roberto Orellana; Anna B Flynn; Paige Padgett Wermuth; Jennifer Kienzle; Garrett Shields; Stefan D Baral
Journal:  BMC Health Serv Res       Date:  2022-09-20       Impact factor: 2.908

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.